Skip to content

YNIOS Pharma

Active
Private limited companyfounded 2022active for 4 yearsAvenue Wolfers 32, 1310 La Hulpe, BelgiumKBO/BCE: BE 0783.494.239
Summary

The computed 12-month bankruptcy probability of YNIOS Pharma is 3.1% (moderate). The 2025 annual accounts show equity of €473,563 and a net result of -€228,903. Equity is growing by about 61% per year across the filed financial years. Its solvency ranks better than 72% of 147 sector peers (NACE 20, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
YNIOS PharmaActiveChecked score 50/100
Risk analysis ReportCompare

Directors

Directors
No directors read yet: 4 of 6 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

We would like to set cookies. That happens only with your consent. What we measure